Clinical trial

Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy

NCT00655330

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2008-05-01

PhaseNA

Study timeline

Study start (unknown)2008-05-01Date precision: month

Registry last updated2016-08-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Nephropathyunresolved

Interventions

ValsartanDRUG · verified · RxNorm: valsartan

PlaceboDRUG

ProbucolDRUG

Sponsors & collaborators

Guangdong Provincial People's Hospitallead sponsor

Mapped research locations

GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00655330 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.